Image

Chronic Subdural Hematoma Treatment With Embolization Versus Surgery Study

Study comparing embolization and surgery for chronic subdural hematoma treatment.

Recruiting
40-90 years
All
Phase N/A
**Chronic Subdural Hematoma Treatment With Embolization Versus Surgery Study** This study looks at treating chronic subdural hematoma (CSDH), which is a condition where blood collects on the brain's surface. The study compares two treatments: middle meningeal artery embolization (MMAE), a procedure that blocks blood flow to reduce bleeding, and conventional open surgery, which involves opening the skull to remove the blood. Participants will share their medical history, have physical exams, give blood samples, and have CT scans of their heads. They will also answer questions and either undergo MMAE or surgery. Researchers want to see if MMAE reduces the need for more surgery or deaths and check its safety compared to surgery. **Key Points:** - The study is for people aged 40-90 with specific CSDH conditions. - Participants will be randomly assigned to one of the treatments and must be ready within 72 hours. - The study involves medical tests, treatment, and sharing medical history. This study helps find safer ways to treat CSDH. Participants should be aware of the process and their role in the study.
Study details
    Chronic Subdural Hematoma

NCT06347796

The University of Texas Medical Branch, Galveston

11 April 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.